ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm

by Anumana  · Based in United States → — Revolutionizing heart care with breakthrough AI that empowers clinicians to identify hidden heart conditions from a simple 12-lead ECG.
Cardiology Internal Medicine Pulmonology

Regulatory Status Disclosed

Overview

The ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm, developed by Anumana, Inc., is an innovative artificial intelligence tool designed to assist clinicians in the early identification of pulmonary hypertension. This algorithm analyzes standard 12-lead electrocardiogram (ECG) recordings, a widely available and non-invasive diagnostic test, to detect subtle patterns indicative of PH.

Pulmonary hypertension is a serious and progressive condition that often goes undiagnosed until advanced stages, leading to poorer patient outcomes. By leveraging AI, Anumana’s algorithm aims to provide a rapid and accessible screening tool that can prompt earlier investigation and intervention, potentially improving the prognosis for affected individuals. The algorithm processes digital ECG data to generate a risk score or flag, alerting physicians to the potential presence of PH.

This technology represents a significant step forward in utilizing AI for cardiovascular diagnostics, transforming routine ECGs into a more powerful screening tool. Its integration into clinical workflows could enable more proactive management of PH, reducing diagnostic delays and facilitating timely referrals to specialists for definitive diagnosis and treatment.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered 12-lead ECG analysis
  • Detection of pulmonary hypertension indicators
  • Non-invasive screening tool
  • Potential for early diagnosis
  • Integration with existing ECG workflows
  • Risk stratification for PH

Use Cases

  • Screening for pulmonary hypertension in at-risk populations
  • Assisting primary care physicians in identifying PH
  • Supporting cardiologists and pulmonologists in diagnostic pathways
  • Reducing diagnostic delays for pulmonary hypertension

What Physicians Need to Know

ECG/EKG Analysis Capability
Anumana's ECG-AI® analyzes 60,000 ECG data points from standard 12-lead ECGs to identify cardiac disease signals invisible to the human eye, delivering binary findings to support ongoing care. The company recently secured FDA clearance for its ECG-AI algorithm for early detection of Pulmonary Hypertension.
Physician Tip

The ECG-AI Pulmonary Hypertension algorithm can transform standard 12-lead ECGs into a powerful tool for early detection of PH, potentially enabling earlier intervention and improved patient outcomes. It integrates seamlessly into existing clinical workflows without requiring new systems or disruptions.

Anumana's platform is designed for seamless and secure integration directly within your EHR and on your own servers. It supports EHR configuration for orderables, results viewing, HL7 data exchange, and CPT III codes for charge capture. It also integrates with compatible ECG Management Systems by configuring digital waveform files (XML or DICOM) for automated processing, with algorithmic processing occurring entirely within the ECG management system framework.

Details

Category Cardiology AI, Clinical Decision Support & Reference, Lab & Diagnostics
Pricing Unknown
DeploymentIntegrates with EHR systems, including ECG management platforms, and runs entirely within the health system environment without transferring patient data.
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Internal Medicine, Pulmonology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm.

Loading videos...

View all on YouTube

Frequently Asked Questions

The ECG-AI PH algorithm analyzes standard 12-lead ECGs to provide insights for earlier identification of pulmonary hypertension.
The algorithm is intended for clinicians to help identify at-risk patients earlier and inform ongoing care for pulmonary hypertension.
The ECG-AI PH algorithm integrates directly within your EHR and can work with compatible ECG management systems.
Setup involves configuring virtual machine requirements, network access, and installing the ECG-AI framework software within your IT infrastructure.
The website text does not specify limitations for the ECG-AI PH algorithm beyond its intended use as a tool for earlier identification.

Related Tools

Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System, ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions, USA
Cardiology AI
Siemens Healthineers offers advanced AI-powered ultrasound systems, including the ACUSON Origin for comprehensive cardiovascular care and the ACUSON Sequoia for high-performance general imaging with BioAcoustic™ technology.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA
Cardiology AI
Siemens Healthineers offers the ACUSON Sequoia, ACUSON Sequoia Select, and ACUSON Origin ultrasound systems, providing advanced imaging for various medical needs. The Sequoia line focuses on high-resolution imaging with deep penetration and reduced variability, while the AI-powered ACUSON Origin specializes in comprehensive cardiovascular diagnostics and interventions.
R30 Diagnostic Ultrasound System
Samsung Medison Co.
Cardiology AI
The Samsung Medison R30 Diagnostic Ultrasound System is a general-purpose, mobile, software-controlled diagnostic ultrasound system that offers a wide range of imaging capabilities and analysis tools for various clinical applications.

See all Cardiology AI tools →

More from Anumana

ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
Low Ejection Fraction AI-ECG Algorithm
Anumana
Cardiology AI
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-08-19 | First Added: 2026-08-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.